Synthesis and characterization of biologically important quinoline incorporated triazole derivatives

•Twelve novel quinoline-triazoles were synthesized.•Novel compounds were characterized by FT IR, NMR and Mass spectral analysis.•Evaluated for antibacterial and antifungal activities.•The novel compounds exhibited moderate to good antimicrobial activities. Triazoles are well recognized in literature...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular structure 2021-04, Vol.1229, p.129503, Article 129503
Hauptverfasser: D'Souza, Vineetha Telma, Nayak, Janardhana, D'Mello, Desmond Edward, Dayananda, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Twelve novel quinoline-triazoles were synthesized.•Novel compounds were characterized by FT IR, NMR and Mass spectral analysis.•Evaluated for antibacterial and antifungal activities.•The novel compounds exhibited moderate to good antimicrobial activities. Triazoles are well recognized in literature for their significant biologically active heterocyclic compounds. Also the quinoline nucleus found in several natural products shows a varied biological activity. Keeping in the view of these observations, a novel series of 6/7/8-substtuted-2-[(5-((4-chlorophenoxy)methyl)-4H-1,2,4-triazol-3-yl)thio]quinoline-3-carbaldehydes and 6/7/8-substituted-2-[(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio]quinoline-carbaldehydes were synthesized by the condensation of 5-(4-chloro phenoxy methyl)-2,4-dihydro-1,2,4-triazole-3-thiones and 5-(pyridin-3-yl)-4H-1,2,4-triazole-3-thiols with 6/7/8-substituted-2-chloro quinoline-3-carbaldehydes. The new series were established by Mass, NMR and IR spectroscopy and were also screened for their antimicrobial activities. A few of the novel compounds exhibited tremendous bioactivities compared to that of normal drug. [Display omitted]
ISSN:0022-2860
1872-8014
DOI:10.1016/j.molstruc.2020.129503